Trial · NCT00537680
Results by group36
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 36
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in the International Cooperative Ataxia Rating Scale (ICARS) From Baseline Assessment to Week 24 | Mid Dose Idebenone | -2.5 | Standard Deviation 6.3 | ICARS points | |
| Change in the International Cooperative Ataxia Rating Scale (ICARS) From Baseline Assessment to Week 24 | High Dose Idebenone | -2.4 | Standard Deviation 4.8 | ICARS points | |
| Change in the International Cooperative Ataxia Rating Scale (ICARS) From Baseline Assessment to Week 24 | Placebo | -1.3 | Standard Deviation 4.4 | ICARS points | |
| Change in Friedreich's Ataxia Rating Scale (FARS) Scores From Baseline to Week 24 | Mid Dose Idebenone | -1.6 | Standard Deviation 6.52 | FARS score | |
| Change in Friedreich's Ataxia Rating Scale (FARS) Scores From Baseline to Week 24 | High Dose Idebenone | -1.2 | Standard Deviation 4.53 | FARS score | |
| Change in Friedreich's Ataxia Rating Scale (FARS) Scores From Baseline to Week 24 | Placebo | 0.6 | Standard Deviation 5.91 | FARS score | |
| Activities of Daily Living (ADL) of Friedreich's Ataxia Rating Scale (FARS), Change in ADL (Total Score ) From Baseline to Week 24 | Mid Dose Idebenone | 0.2 | Standard Deviation 2.45 | ADL points | |
| Activities of Daily Living (ADL) of Friedreich's Ataxia Rating Scale (FARS), Change in ADL (Total Score ) From Baseline to Week 24 | High Dose Idebenone | 0.6 | Standard Deviation 3.13 | ADL points | |
| Activities of Daily Living (ADL) of Friedreich's Ataxia Rating Scale (FARS), Change in ADL (Total Score ) From Baseline to Week 24 | Placebo | 1.0 | Standard Deviation 2.97 | ADL points | |
| Change in the International Cooperative Ataxia Rating Scale (ICARS) From Baseline Assessment to Week 12 | Mid Dose Idebenone | -1.5 | Standard Deviation 5.35 | ICARS points | |
| Change in the International Cooperative Ataxia Rating Scale (ICARS) From Baseline Assessment to Week 12 | High Dose Idebenone | -1.6 | Standard Deviation 5.53 | ICARS points | |
| Change in the International Cooperative Ataxia Rating Scale (ICARS) From Baseline Assessment to Week 12 | Placebo | -3.0 | Standard Deviation 3.52 | ICARS points | |
| Absolute Change From Baseline to Week 24 in the Relative Wall Thickness (RWT) of the Left Ventricle | Mid Dose Idebenone | -0.032 | Standard Deviation 0.096 | cm | |
| Absolute Change From Baseline to Week 24 in the Relative Wall Thickness (RWT) of the Left Ventricle | High Dose Idebenone | 0.007 | Standard Deviation 0.071 | cm | |
| Absolute Change From Baseline to Week 24 in the Relative Wall Thickness (RWT) of the Left Ventricle | Placebo | 0.010 | Standard Deviation 0.097 | cm | |
| Percent Change From Baseline to Week 24 in the Relative Wall Thickness (RWT) of the Left Ventricle | Mid Dose Idebenone | -3.32 | Standard Deviation 15.300 | % change | |
| Percent Change From Baseline to Week 24 in the Relative Wall Thickness (RWT) of the Left Ventricle | High Dose Idebenone | 1.53 | Standard Deviation 12.560 | % change | |
| Percent Change From Baseline to Week 24 in the Relative Wall Thickness (RWT) of the Left Ventricle | Placebo | 2.65 | Standard Deviation 17.135 | % change | |
| Absolute Change From Baseline to Week 24 in Left Ventricular Mass Index (LVMI) | Mid Dose Idebenone | -3.06 | Standard Deviation 6.23 | g/m2 | |
| Absolute Change From Baseline to Week 24 in Left Ventricular Mass Index (LVMI) | High Dose Idebenone | -2.56 | Standard Deviation 4.27 | g/m2 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00537680/results